Biomaxima (WAR:BMX) Short-Term Debt : zł2.59 Mil (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biomaxima Short-Term Debt?

Biomaxima's Short-Term Debt for the quarter that ended in Mar. 2024 was zł2.59 Mil.

Biomaxima's quarterly Short-Term Debt increased from Sep. 2023 (zł3.30 Mil) to Dec. 2023 (zł3.55 Mil) but then declined from Dec. 2023 (zł3.55 Mil) to Mar. 2024 (zł2.59 Mil).

Biomaxima's annual Short-Term Debt declined from Dec. 2021 (zł8.14 Mil) to Dec. 2022 (zł1.31 Mil) but then increased from Dec. 2022 (zł1.31 Mil) to Dec. 2023 (zł3.55 Mil).

Biomaxima Short-Term Debt Historical Data

The historical data trend for Biomaxima's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomaxima Short-Term Debt Chart

Biomaxima Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

5.65

4.14

8.14

1.31

3.55

Biomaxima Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															-	3.43	3.30	3.55	2.59

Biomaxima Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Biomaxima Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Biomaxima's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomaxima (WAR:BMX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Biomaxima SA (WAR:BMX) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

944:Germany

Address

5 Vetterow Street, Lublin, POL, 20-277

Website

http://www.biomaxima.com

Biomaxima SA is a Polish company, produces microbiology media as well as a wide range of reagents and in Vitro diagnostics equipment. The company is also a distributor of products of recognized global diagnostics companies such as Nova Biomedical, Mitsubishi Chemical and Biologist. Its products include Systems Antibiotic Susceptibility Testing, Urine Analysis Systems, Hematological Reagents along with Analyzers, ion Selective Analyzers with Reagents, Immunological Analyzer of Cardiac markers with reagents, Glucose Meters and analyzers for Gasometric and Critical Blood Tests.

Biomaxima (WAR:BMX) Headlines

No Headlines